GSK Investigational Site

Winter Park, Florida 32792

0 studies enrolling now · 28 studies all time

What they study most

Anaemia, Aspergillosis, Allergic Bronchopulmonary, Asthma, Bipolar Disorder, Bowel Dysfunction, Constipation, Depressive Disorder, Depressive Disorder, Major, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Major Depressive Disorder (MDD), Mood Disorders

Studies at this site

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma — Completed
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) — Completed
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma — Completed
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy. — Completed
Asthma Exacerbation Study — Completed
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study — Completed
A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD — Completed
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder — Stopped early
Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy. — Completed
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. — Completed
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. — Completed
Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients — Completed
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy. — Completed
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only — Completed
An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder — Completed
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia — Completed
Rosiglitazone on Microalbuminuria in Type 2 Diabetics — Completed
Bipolar Study in Adults at Least 18 Years of Age — Completed
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed
Study Of GW679769 In Major Depressive Disorder — Completed
An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder — Completed
Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy — Completed